New ENDOTARGET scientific publication

Have a look on our publication “β boswellic acid blocks articular innate immune responses: an in silico and in vitro approach to traditional medicine” from the ENDOTARGET consortium.

By using computational pharmacology, proteomics, transcriptomics, and metabolomics a solid evidence of β boswellic acid (BBA) therapeutic properties in mouse and primary human OA joint cells could be presented in this study. BBA blocks osteoarthritis innate immune responses and could be transferred into the clinic as an alimentary supplement or as a therapeutic tool after clinical trial evaluations.

To read this publication visit our “publications” section!